These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7624111)

  • 21. Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies.
    Lane DM; Eagle KF; Begent RH; Hope-Stone LD; Green AJ; Casey JL; Keep PA; Kelly AM; Ledermann JA; Glaser MG
    Br J Cancer; 1994 Sep; 70(3):521-5. PubMed ID: 8080740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor targeting and pharmacokinetics of unmodified and modified F(ab)2 fragments of an anti-CEA murine monoclonal antibody (Immu-14).
    Siddiqui A; Quadri SM; Griffiths GL; Goldenberg DM; Vriesendorp HM
    Nucl Med Biol; 1995 May; 22(4):425-35. PubMed ID: 7550018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodistribution and tumor localization of 111In-labeled unmodified and modified F(ab')2 fragments of human monoclonal IgM (16.88) in a nude mouse model.
    Quadri SM; Siddiqui A; Klein JL; Vriesendorp HM
    Nucl Med Biol; 1995 May; 22(4):413-23. PubMed ID: 7550017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery.
    Kim JC; Roh SA; Koo KH; Ryu JH; Hong HK; Oh SJ; Ryu JS; Kim HJ; Bodmer WF
    Int J Cancer; 2002 Feb; 97(4):542-7. PubMed ID: 11802220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
    Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
    Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
    Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC
    Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of IgG and F(ab')2 fragments of bispecific anti-RCCxanti-DTIn-1 antibody for pretargeting purposes.
    van Schaijk FG; Boerman OC; Soede AC; McBride WJ; Goldenberg DM; Corstens FH; Oosterwijk E
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1089-95. PubMed ID: 15902440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative tumor localization of whole immunoglobulin G anticarcinoembryonic antigen monoclonal antibodies IMMU-4 and IMMU-4 F(ab')2 in colorectal cancer patients.
    Murray JL; Rosenblum MG; Zhang HZ; Podoloff DA; Kasi LP; Curley SA; Chan JC; Roh M; Hohn DC; Brewer H
    Cancer; 1994 Feb; 73(3 Suppl):850-7. PubMed ID: 8306270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
    Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
    J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of unlabelled monoclonal antibodies on the biodistribution of 111In-labelled anti-prostate-specific acid phosphatase monoclonal antibodies in the mouse model.
    Peräalä-Heape M; Vihko P; Vihko R
    Anticancer Res; 1991; 11(3):1327-31. PubMed ID: 1888168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy and imaging of pancreatic carcinoma xenografts with radioiodine-labeled chimeric monoclonal antibody A10 and its Fab fragment.
    Kamigaki T; Yamamoto M; Ohyanagi H; Ohya M; Shimazoe T; Kono A; Ohtani W; Narita Y; Ohkubo M; Saitoh Y
    Jpn J Cancer Res; 1995 Dec; 86(12):1216-23. PubMed ID: 8636013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superior localisation and imaging of radiolabelled monoclonal antibody E48 F(ab')2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody E48 IgG.
    Gerretsen M; Quak JJ; Suh JS; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Br J Cancer; 1991 Jan; 63(1):37-44. PubMed ID: 1989663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative biodistribution and radioimmunotherapy of monoclonal antibody RS7 and its F(ab')2 in nude mice bearing human tumor xenografts.
    Stein R; Blumenthal R; Sharkey RM; Goldenberg DM
    Cancer; 1994 Feb; 73(3 Suppl):816-23. PubMed ID: 8306265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma.
    Vuillez JP; Moro D; Brambilla E; Brichon PY; Ferretti G; Saccavini JC; Brambilla C
    Eur J Cancer; 1994; 30A(8):1089-92. PubMed ID: 7654435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct comparison of a radioiodinated intact chimeric anti-CEA MAb with its F(ab')2 fragment in nude mice bearing different human colon cancer xenografts.
    Vogel CA; Bischof-Delaloye A; Mach JP; Pèlegrin A; Hardman N; Delaloye B; Buchegger F
    Br J Cancer; 1993 Oct; 68(4):684-90. PubMed ID: 8398694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibody.
    Marshall D; Pedley RB; Melton RG; Boden JA; Boden R; Begent RH
    Br J Cancer; 1995 Jan; 71(1):18-24. PubMed ID: 7529526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diverse characteristics of 111In labelled anti-CEA monoclonal antibodies for tumour immunoscintigraphy: radiolabelling, biodistribution and imaging studies in mice with human tumour xenografts.
    Pimm MV; Perkins AC; Baldwin RW
    Eur J Nucl Med; 1987; 12(10):515-21. PubMed ID: 3569340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.
    Patt YZ; Podoloff DA; Curley S; Smith R; Badkhamkar VA; Lamki LM; Jessup MM; Hohn DC
    Cancer; 1993 Jun; 71(12 Suppl):4293-7. PubMed ID: 8389662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-covalent antibody-mediated drug delivery.
    Lollo C; Halpern S; Bartholomew R; David G; Hagan P
    Nucl Med Commun; 1994 Jun; 15(6):483-91. PubMed ID: 8078646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.